Altus GP| Commercial Real Estate Investments

Dr. Preetpal Singh Sidhu, PhD, NRCC, ASCP

Founder & Managing Member – Altus Capital AM LLC

The Story of Dr. Preetpal Singh Sidhu

Dr. Preetpal Singh Sidhu's story begins in Dhaban, Rajasthan, a village in northern India known for its close-knit rural culture and deep sense of community. Raised in a simple family with an agricultural background, he grew up surrounded by the values of hard work, humility, discipline, and resilience— qualities that would later define his journey as a scientist, entrepreneur, and CEO. From an early age, he learned to see limitations not as barriers, but as invitations to think bigger and work harder.

His academic path first took him to Bangalore, where he earned his bachelor's degree in Pharmacy. That period expanded his world: it exposed him to rigorous scientific training, sharpened his curiosity about medicine and drug discovery, and laid the technical foundation for everything that followed. It was in these formative years that his interest in the intersection of chemistry, health, and innovation truly began to take shape.

In 2007, Dr. Sidhu moved to the United States with a larger dream and a willingness to build a future from the ground up. He pursued a PhD in Medicinal Chemistry at Virginia Commonwealth University, where he immersed himself in advanced research and developed expertise in drug discovery and molecular science. The move marked more than a change in geography—it represented a defining leap of ambition, adaptation, and perseverance. In laboratories, classrooms, and research collaborations, he refined the scientific discipline that would become central to his professional identity.

That journey—from a small village in Rajasthan to advanced scientific research, entrepreneurship, and philanthropy in the United States—helps explain the leadership vision reflected in every business Dr. Sidhu has built. He has shaped his career by combining scientific depth with entrepreneurial courage, transforming education into innovation and innovation into meaningful impact. The accomplishments outlined below in diagnostics, investment, research, and philanthropy are not isolated achievements; they are chapters in a larger story of determination, continuous learning, and purpose-driven leadership.

Executive Summary

As the Founder and Managing Member of Altus Capital AM LLC, Dr. Preetpal Singh Sidhu leads a Kentucky-based alternative asset management firm focused on unlocking value through science-driven investment strategies, real estate acquisition, and venture development. He is also a pioneer in healthcare innovation as the founder of Solaris Diagnostics and Biopathogenix, and an active contributor to community well-being through his extensive philanthropic efforts.

Investment & Business Leadership

In 2022, Dr. Sidhu founded Altus Capital AM, bringing together his deep operational background with a forward-looking investment philosophy. The firm is committed to alternative asset classes with a particular interest in:

Specialty real estate development & management

Private equity in regulated industries: retail, entertainment, and hospitality

In parallel with his investment activities, Dr. Sidhu has led several real estate acquisition and development projects across Kentucky to Florida, focusing on strategic commercial and retail infrastructure. His dual role as a real estate investor and life sciences executive enables a unique understanding of the ecosystems that support biotech growth.

In 2020, Dr. Sidhu co-founded Desi Capital a private lending company with a focus on retail operations: gas stations, liquor stores, event spaces, and social clubs.

Healthcare Innovation

Dr. Sidhu is the Founder of Solaris Diagnostics, a high-complexity, CLIA-certified laboratory in Nicholasville, KY, delivering state-of-the-art molecular diagnostics, toxicology, and infectious disease testing. His leadership ensures rigorous compliance, precision testing, and continuous innovation in diagnostics. He made a successful exit from Solaris in 2024.

He is also the Founder of Biopathogenix, a biotechnology enterprise focused on developing advanced molecular tools for diagnostic and therapeutic applications. Biopathogenix reflects Dr. Sidhu’s dedication to expanding diagnostic capabilities and reducing healthcare disparities through innovation.

Bioventures Capital was founded by Dr. Sidhu in 2025. It is a “ “ company that focuses on investing & commercializing early stage biotechnology and diagnostics start-ups.

Academic Credentials & Scientific Impact

Dr. Sidhu earned his PhD in Medicinal Chemistry from Virginia Commonwealth University, where he designed allosteric inhibitors of thrombin as part of his groundbreaking thesis research. He has held postdoctoral positions and research fellowships at:

Virginia Commonwealth University

University of Wisconsin–Milwaukee

Over the past two decades, Dr. Sidhu has made significant contributions to the field of clinical chemistry and drug discovery. His research has led to over 20 peer-reviewed publications covering:

Vitamin D receptor antagonists

Anticoagulant design

ADME profiling

Oncological pharmacology

He is board-certified in Clinical Chemistry (NRCC) and licensed as a Laboratory Director in multiple states, with additional certification as a Technologist in Chemistry (ASCP).

Philanthropy & Community Engagement

Dr. Sidhu is a steadfast advocate for community health and access. Through Solaris Diagnostics, he has led efforts to partner with regional health organizations, most notably donating incentives to blood donors during National Blood Donor Month to support the Kentucky Blood Center. In 2020 Dr. Sidhu facilitated over 1000 oxygen concentrators to be flown to India during the pandemic. He has supported various entities in Kentucky to recover flood damages. He also sponsors children’s underprivileged day cares.

His philanthropic initiatives extend to:

Scholarship programs for underserved students in STEM fields

Public health education outreach in rural Kentucky communities

Support for early-stage minority entrepreneurs in healthcare

These efforts reflect his core belief that innovation and compassion must go hand in hand in building healthier, more equitable societies.

Summary

Dr. Preetpal Singh Sidhu’s career spans clinical excellence, entrepreneurial innovation, and strategic capital deployment. Whether in the laboratory, the boardroom, or the community, he brings an unwavering commitment to scientific integrity, impactful investment, and service to others. Through Altus Capital AM, Desi Capital, Solaris Diagnostics, and Biopathogenix, Dr. Sidhu is building a legacy defined by precision, purpose, and progress.

Publications

Rational design of potent, small, synthetic allosteric inhibitors of thrombin
Journal of medicinal chemistry, 2011/8/11
Authors: Preetpal Singh Sidhu, Aiye Liang, Akul Y Mehta, May H Abdel Aziz, Qibing Zhou, Umesh R Desai